# A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers

> **NCT00990015** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 27 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** PF-04308515
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00990015
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2010-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00990015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00990015, "A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00990015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*